Industry Update View All
Thriving Beyond the Challenges of Multiple Myeloma Post- Transplantation

Multiple myeloma (MM) is a clonal plasma cell disorder characterised by excess production of monoclonal immunoglobulins and light chains that can ultimately lead to specific end-organ damage 1 . Notably, MM is the second most common haematologic mal...

Dr. Mohsin RoshanOct 22, 2024
Optimising Protein Intake in Patients with Chronic Kidney Disease

Chronic kidney disease (CKD) is a global public health problem that an estimated 843.6 million individuals are currently affected by various stages of the disease, whereas the prevalence of CKD is increasing, and Hong Kong is no exception1. Yet, the...

Dr. Roy LauOct 22, 2024
The Unmet Needs in Relapse/ Refractory Multiple Myeloma: A Clinical Challenge

Multiple myeloma (MM) is a haematologic malignancy characterised by abnormal clonal plasma cells in the bone marrow with a potential for uncontrolled growth causing destruction, osseous lesion, acute kidney injury (AKI), anaemia, and hypercalcaemia....

Dr. Mohsin RoshanAug 20, 2024
FeaturedView All